ClinicalTrials.gg
Sign In

Leukemia, Biphenotypic, Acute clinical trials

The registry lists 246 studies for Leukemia, Biphenotypic, Acute across more than 10 countries. 56 are recruiting or about to start. 62 of them are mainly about Leukemia, Biphenotypic, Acute (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Leukemia, Biphenotypic, Acute studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
121
Recruiting
49
Active, not recruiting
26
Terminated
20
Withdrawn
14
Status unknown
9

Phase

Phase 2
108
Phase 1
97
Phase 3
31
Early Phase 1
3
Phase 4
1

Where

United States
195
Canada
22
Australia
14
Italy
12
France
12
Germany
10

Who runs them

Fred Hutchinson Cancer Center (32) · M.D. Anderson Cancer Center (22) · National Cancer Institute (NCI) (18) · Children's Oncology Group (14) · Memorial Sloan Kettering Cancer Center (10) · St. Jude Children's Research Hospital (7) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (6) · European Organisation for Research and Treatment of Cancer - EORTC (5)

What is being tested here

Drugs under test in Leukemia, Biphenotypic, Acute studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fludarabine7126
Cyclophosphamide6123
Venetoclax6013
Revumenib608
Cytarabine4014
Blinatumomab428
Azacitidine308
Cladribine307
Idarubicin304
Fludarabine phosphate2114

Drug classes tested here Antimetabolites 18 open · Alkylating agents 9 open · Tyrosine kinase inhibitors (TKIs) 4 open · Corticosteroids 3 open · Antimitotic agents 2 open

Coming up

10phase 3 studies under way
24studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 49 Leukemia, Biphenotypic, Acute studies recruiting now, 21 (43%) set no upper age limit and 22 (45%) stop at 75 or younger. 30 (61%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (6%) take healthy volunteers.

Recruiting studies that take each age, of 49
AgeWomenMen
1019 (39%)19 (39%)
1846 (94%)46 (94%)
3038 (78%)38 (78%)
4037 (76%)37 (76%)
5036 (73%)36 (73%)
6535 (71%)35 (71%)
7531 (63%)31 (63%)
8524 (49%)24 (49%)

Across all 246 studies, recruiting or not: 49% stop at 75 or younger and 37% at 65; 58% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Biphenotypic, Acute studies take

Of 42 phase 2 interventional studies under Leukemia, Biphenotypic, Acute, half reached primary completion within 102 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 170 mo29–98 · 27 studies——
Phase 2102 mo47–153 · 42 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 246. Browse all 246 → or search them.